What predicts patients' perceptions of improvement in insomnia?

Department of Clinical Health Psychology, University of Manitoba, Winnipeg, Manitoba, Canada.
Journal of Sleep Research (Impact Factor: 3.35). 10/2006; 15(3):301-8. DOI: 10.1111/j.1365-2869.2006.00529.x
Source: PubMed


Although there has been considerable research into the effectiveness of individual cognitive behavioral treatment for chronic insomnia, less is known about patients' perceptions of what constitutes actual improvement. This study utilized 70 outpatients (mean age = 49.7 years, SD = 12.0) with insomnia who completed a 6-week cognitive behavioral group for sleep. Participants completed a number of primary (Pittsburgh Sleep Quality Index) and secondary measures (the Dysfunctional Beliefs about Sleep Scale, Insomnia Severity Index, Beck Depression Inventory, Penn State Worry Questionnaire) at pre- and post-treatment. Perceived improvement was measured using the Clinical Global Improvement Scale (CGI). Results were analyzed using a combination of Logistic Regression analysis and receiver operating curve characteristic analysis (ROC). Results demonstrated that sleep quality and sleep duration were the most sensitive primary measures, or best predicted perceived improvement, whereas sleep efficiency was the most specific primary measure, or best predicted perceived lack of improvement (defined as only mild improvement). Of the secondary measures, results showed that daytime impairment was the most sensitive predictor of perceived improvement and that mood was the most specific predictor of perceived lack of improvement. Implications of these findings are that sleep quality, sleep duration, and sleep efficiency may offer different types of information and the choice of measure for predicting global improvement in insomnia will depend on the needs of the researcher/clinician.

Download full-text


Available from: Norah Vincent, Sep 29, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Insomnia is a highly prevalent disorder with consequences for the patient's physical and mental health, daily function, and job performance. Although the exact pathophysiology of insomnia is unknown, recent research has demonstrated that normal sleep and wakefulness are controlled by reciprocal inhibition by different brain regions. This sleep-wake control system offers multiple therapeutic targets for the treatment of insomnia; currently, most research and available hypnotic agents target gamma-aminobutyric acid (GABA) on the sleep side of the switch. Historically, drugs have evolved from benzodiazepine receptor agonists to nonbenzodiazepines to, most recently, selective extrasynaptic GABA(A) receptor agonists. However, these drugs have a differential impact on characteristics of sleep. Among the compounds that modulate the benzodiazepine-sensitive GABA(A) receptors, benzodiazepines suppress stage 3-4 sleep, whereas nonbenzodiazepines have no substantial effect on these stages of sleep. Recently, work on GABA agonists indicates that they increase stage 3-4 sleep. This has been demonstrated via sleep-stage scoring as well as with spectral analysis. Further, this increase in stage 3-4 sleep is associated with a decrease in stage 1 sleep and arousals from sleep. Thus, the GABA agonists may not simply promote sleep, but consolidate it as well. The clinical utility of the increase in slow-wave sleep and the sleep consolidation it produces warrants further investigation.
    Preview · Article · Feb 2007 · The Journal of Clinical Psychiatry
  • [Show abstract] [Hide abstract]
    ABSTRACT: Sleep performs an essential function in humans. Insomnia is one of the common phenomena in a poor sleep pattern. Long-term suffering can result in somatic symptoms and the development of diseases. It can even induce diseases with a mental dimension. Insomnia causes indications of poor health. No systematic analysis of insomnia has been performed, however. The purpose of this study, therefore, was to describe the concept of insomnia. In accordance with Walker and Avant's (2005) methodology of concept analysis, this paper presents a review of the conceptual definitions, characteristics, antecedents and consequences, constructing examples, and empirical references of insomnia. The results indicate that: (1) Insomnia's defining attributes are recognized as an insufficient of quality and quantity for sleep for more than one month. (2) Antecedents of insomnia include changes in life habits, physiological demands caused by sleep time changes, and the experience of uncomfortable sensations. (3) Consequences of insomnia include a poor condition, with physical, psychological, social, and global dimensions. (4) There are many instruments that can be used to inspect insomnia, including questionnaires and tools for physiological measurement. Insomnia is a serious problem with various facets. An understanding of the concept of insomnia will help nurses to perceive this problem in caring for subjects.
    No preview · Article · Nov 2008 · Hu li za zhi The journal of nursing
  • [Show abstract] [Hide abstract]
    ABSTRACT: Sleep disturbances have a major influence on quality of life. A commonly used measure of sleep disturbances is sleep efficiency. The purpose of this study was to investigate the prevalence of decreased subjective sleep efficiency in hemodialysis patients. An additional goal was to identify clinical, dialysis or laboratory parameters that are independently associated with decreased sleep efficiency. Adult stable hemodialysis patients (n = 112) filled out a sleep questionnaire during a three day investigation period. In addition, healthy control subjects (n = 44) filled out the same questionnaire. From this questionnaire sleep efficiency (ratio of total sleep time to time spent in bed) was derived as a measure for sleep disturbances in this population. Laboratory, demographic and dialysis data were collected during the investigation period. For statistical analysis linear regression models were used. Median subjective sleep efficiency in hemodialysis patients was 80%, which was significantly less compared to the median subjective sleep efficiency of control subjects of 88% (p pound 0.05). Approximately 40% of the patients used sleep medication. However, less than 20% of them indicated improved sleep behavior when using these drugs. Elevated levels of phosphate and urea correlated independently with impaired sleep efficiency. Hemoglobin levels between 10 and 12 g/dl were associated with better sleep efficiency. In conclusion, decreased sleep efficiency was frequently reported in hemodialysis patients and can be associated with biochemical parameters. Hemoglobin, phosphate and urea levels can affect subjective sleep efficiency.
    No preview · Article · Dec 2008 · Clinical nephrology
Show more